Candela was delighted earlier this year to receive an award for its Nordlys device, in a hotly fought category with 10 devices shortlisted. 

Read just some of the reasons the Nordlys device was selected for the Aesthetic Awards Energy-based Device of the Year 2022.

Meeting patients’ needs is key to a successful business and investing in a device which has the ability to grow with your patients and practice demands is a sensible business decision.

The Nordlys system enables you to meet the increasing demand for aesthetic and dermatological procedures with a single multiapplication platform that is CE-marked for 24 indications. 

Developed over 20 years and using three foundational technologies, Ellipse IPL, (with the patented Selective Waveband Technology) Frax 1550/1940, and Nd:YAG 1064, this device is the cornerstone of numerous clinics, worldwide.

With 20 years of clinical experience, the Nordlys system is one of the most proven multiapplication systems available in the market today. 

What makes Nordlys different?

Comfort: SoftCool sends a focused stream of cool air for greater comfort during and after the treatment. 

Ease of use: the device is quiet in operation, providing a relaxed environment for both operator and the person being treated.

More treatment options: the Nordlys device gives you the option of using either a laser or light-based technology. 

Fewer treatments: the combination of lower fluence and narrowband results in fewer treatments.

All-season treatment: the Nordlys system can be used on skin types I-VI, in any season and any climate.

What technologies are included in Nordlys?

Ellipse IPL: designed for photo-rejuvenation, small vascular lesions and diffused redness.

FRAX 1550 and FRAX 1940: for non-ablative skin resurfacing and treatment of acne scars, scars, and striae.

ND: YAG 1064: designed to treat benign vascular lesions such as: leg veins, venous lakes, resistant port wine stains, onychomycosis and warts

SOURCEAesthetics Medicine
Previous articleSinclair unveils new rebrand
Next articleNew Allergan Aesthetics Report Highlights What’s to Come